Register for our free email digests:
Seneca Biopharma Inc.
www.neuralstem.com
Latest From Seneca Biopharma Inc.
Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers
Deal follows 2013 pact between Ambrx and NovoCodex parent Zhejiang Medicine for HER2-positive-directed ADC. Astellas teams with Pandion on pancreatic cancer and Takeda with MD Anderson on CAR NK therapies.
ITF Pharma Plans October US Roll-Out Of Liquid Riluzole Formulation For ALS
Early engagement with US payers suggests openness to covering a liquid form of riluzole, because the tablet version is proven, but it's impossible to take for many ALS patients, says Italfarmaco subsidiary ITF Pharma.
Pipeline Watch: Phase III Starts With Bavencio, MultiStem And VT-1161
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Phase III Studies of CSL112 And RT-100 Imminent
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
- Synthesis Technologies, Production Processes
- Pharmaceuticals
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Neuralstem Inc.
- NeuralStem BioPharmaceuticals Ltd.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Seneca Biopharma Inc.
- Senior Management
- David Recker, MD, CMO
- Contact Info
-
Seneca Biopharma Inc.
Phone: (301) 366-4960
20271 Goldenrod Lane
2nd Floor
Germantown, MD 20876
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice